266 related articles for article (PubMed ID: 20700042)
1. Novel oral anticoagulants: implications in the perioperative setting.
Levy JH; Key NS; Azran MS
Anesthesiology; 2010 Sep; 113(3):726-45. PubMed ID: 20700042
[TBL] [Abstract][Full Text] [Related]
2. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
Merli G; Spyropoulos AC; Caprini JA
Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
[TBL] [Abstract][Full Text] [Related]
3. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
Ageno W; Spyropoulos AC; Turpie AG
Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in the use of oral anticoagulants.
Lassen MR
Expert Opin Pharmacother; 2009 Aug; 10(11):1769-81. PubMed ID: 19548861
[TBL] [Abstract][Full Text] [Related]
5. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
Ageno W
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.
Stangier J; Clemens A
Clin Appl Thromb Hemost; 2009; 15 Suppl 1():9S-16S. PubMed ID: 19696042
[TBL] [Abstract][Full Text] [Related]
8. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
Martí-Fàbregas J; Mateo J
Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
[TBL] [Abstract][Full Text] [Related]
9. [Novel oral anticoagulants and their use in the perioperative setting].
Schellong SM; Haas S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Apr; 47(4):266-72; quiz 273. PubMed ID: 22504623
[TBL] [Abstract][Full Text] [Related]
10. Factor Xa inhibitors--new anticoagulants for secondary haemostasis.
Perzborn E
Hamostaseologie; 2009 Aug; 29(3):260-7. PubMed ID: 19644596
[TBL] [Abstract][Full Text] [Related]
11. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Muehlhofer E; Dierig C; Misselwitz F; Kälebo P;
Circulation; 2006 Nov; 114(22):2374-81. PubMed ID: 17116766
[TBL] [Abstract][Full Text] [Related]
12. Oral antithrombotic inhibitors: dabigatran etexilate, meeting an unmet need?
Hull R
Clin Appl Thromb Hemost; 2009; 15 Suppl 1():5S-8S. PubMed ID: 19706619
[TBL] [Abstract][Full Text] [Related]
13. New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
Friedman RJ
Orthopedics; 2009 Dec; 32(12 Suppl):79-84. PubMed ID: 20201481
[TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants for prophylaxis and treatment of venous thromboembolism: part I (Factor Xa inhibitors).
Mehta RS
Expert Rev Hematol; 2010 Apr; 3(2):227-41. PubMed ID: 21083465
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery.
Martin MT; Nutescu EA
Curr Med Res Opin; 2011 Nov; 27(11):2123-31. PubMed ID: 21942466
[TBL] [Abstract][Full Text] [Related]
16. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
Turpie AG
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1238-47. PubMed ID: 17379841
[TBL] [Abstract][Full Text] [Related]
17. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
[TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
Zikria JC; Ansell J
Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?
Cohen H; Machin SJ
Lupus; 2010 Apr; 19(4):486-91. PubMed ID: 20353992
[TBL] [Abstract][Full Text] [Related]
20. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
Andersen JC
Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]